PIOGLITAZONE HYDROCHLORIDE
- Product NDC
- 70518-4519
- 11-digit product format
- 705184519
- Labeler code
- 70518
- Product ID
- 70518-4519_4390d6f4-41fe-9b18-e063-6394a90a8031
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- pioglitazone hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA200268
- Marketing category
- ANDA
- Marketing start
- 2025-11-14
- Substance
- PIOGLITAZONE HYDROCHLORIDE
- Active strength
- 45 mg/1
- Pharmacologic classes
- Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- PIOGLITAZONE HYDROCHLORIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PIOGLITAZONE HYDROCHLORIDE | 45 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | JQT35NPK6C |
| Rxcui | 312441 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70518-4519-0 | PIOGLITAZONE HYDROCHLORIDE | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70518-4519-0 | 70518451900 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-4519-0) | 90 tablet | 2025-11-14 | No | No | Current |